Tumor Immunology and Tumor Evolution: Intertwined Histories
- PMID: 31940273
- DOI: 10.1016/j.immuni.2019.12.018
Tumor Immunology and Tumor Evolution: Intertwined Histories
Abstract
Cancer is a complex disease whose outcome depends largely on the cross-talk between the tumor and its microenvironment. Here, we review the evolution of the field of tumor immunology and the advances, in lockstep, of our understanding of cancer as a disease. We discuss the involvement of different immune cells at distinct stages of tumor progression and how immune contexture determinants shaping tumor development are being exploited therapeutically. Current clinical stratification schemes focus on the tumor histopathology and the molecular characteristics of the tumor cell. We argue for the importance of revising these stratification systems to include immune parameters so as to address the immediate need for improved prognostic and/or predictive information to guide clinical decisions.
Keywords: T cells; adaptive immunity; immune contexture; immunoscore; immunotherapy; tumor microenvironment; tumor-immunology.
Copyright © 2020 Elsevier Inc. All rights reserved.
Similar articles
-
Human Anti-tumor Immunity: Insights from Immunotherapy Clinical Trials.Immunity. 2020 Jan 14;52(1):36-54. doi: 10.1016/j.immuni.2019.12.010. Immunity. 2020. PMID: 31940272 Review.
-
Why is immunotherapy effective (or not) in patients with MSI/MMRD tumors?Bull Cancer. 2019 Feb;106(2):105-113. doi: 10.1016/j.bulcan.2018.08.007. Epub 2018 Oct 17. Bull Cancer. 2019. PMID: 30342749 Review.
-
Targeting the tumor microenvironment and T cell metabolism for effective cancer immunotherapy.Eur J Immunol. 2019 Aug;49(8):1147-1152. doi: 10.1002/eji.201848058. Epub 2019 Jul 9. Eur J Immunol. 2019. PMID: 31270810 Review.
-
Understanding genetic determinants of resistance to immune checkpoint blockers.Semin Cancer Biol. 2020 Oct;65:123-139. doi: 10.1016/j.semcancer.2019.12.020. Epub 2019 Dec 24. Semin Cancer Biol. 2020. PMID: 31881338 Review.
-
Coinhibitory Pathways in Immunotherapy for Cancer.Annu Rev Immunol. 2016 May 20;34:539-73. doi: 10.1146/annurev-immunol-032414-112049. Epub 2016 Feb 25. Annu Rev Immunol. 2016. PMID: 26927206 Review.
Cited by
-
Immune landscape of hepatocellular carcinoma tumor microenvironment identifies a prognostic relevant model.Heliyon. 2024 Jan 24;10(3):e24861. doi: 10.1016/j.heliyon.2024.e24861. eCollection 2024 Feb 15. Heliyon. 2024. PMID: 38317886 Free PMC article.
-
Increased Nuclear Transporter KPNA2 Contributes to Tumor Immune Evasion by Enhancing PD-L1 Expression in PDAC.J Immunol Res. 2021 Mar 1;2021:6694392. doi: 10.1155/2021/6694392. eCollection 2021. J Immunol Res. 2021. PMID: 33728352 Free PMC article.
-
Tumor spread or siege immunity: dissemination to distant metastasis or not.Oncoimmunology. 2021 Apr 25;10(1):1919377. doi: 10.1080/2162402X.2021.1919377. Oncoimmunology. 2021. PMID: 33996269 Free PMC article.
-
The pivotal roles of neddylation pathway in immunoregulation.Immun Inflamm Dis. 2020 Dec;8(4):782-792. doi: 10.1002/iid3.335. Epub 2020 Aug 4. Immun Inflamm Dis. 2020. PMID: 32749072 Free PMC article. Review.
-
The Prognostic Impact of Combined Tumor-Infiltrating Lymphocytes and Pretreatment Blood Lymphocyte Percentage in Locally Advanced Nasopharyngeal Carcinoma.Front Oncol. 2022 Jan 18;11:788497. doi: 10.3389/fonc.2021.788497. eCollection 2021. Front Oncol. 2022. PMID: 35117992 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials